Treating HIV/AIDS by reducing immune system activation: the paradox of immune deficiency and immune hyperactivation
Author:
- 1 March 2008
- journal article
- structured treatment-interruption
- Published by Wolters Kluwer Health in Current Opinion in HIV and AIDS
- Vol. 3 (2) , 99-103
Abstract
Purpose of review To collect published evidence in support of a novel immune therapeutic approach to reduce the excess of immune activation that ultimately turns into immune deficiency in HIV/AIDS. Recent findings A large body of evidence has been collected in support of the pathogenetic interpretation that prolonged immune overactivation induced by HIV during the course of chronic infection exhausts the immune system and leads to AIDS. Some groups are exploring the possibility of therapeutic interventions to limit the immune system overload. Cytostatic drugs appear promising candidates to achieve the goal, as they restrain cell proliferation without blocking it. At the same time, they do not affect cellular response to antigenic stimulation, and at appropriate dosages are not immune suppressive. Summary Presently available antiretrovirals only partially reduce immune system activation during chronic HIV infection. Further clinical research is warranted to test cytostatic drugs to avert immune overactivation and prevent progression to AIDS.Keywords
This publication has 33 references indexed in Scilit:
- A Checkpoint in the Cell Cycle Progression as a Therapeutic Target to Inhibit HIV ReplicationThe Journal of Infectious Diseases, 2007
- Quantification of the Effects on Viral DNA Synthesis of Reverse Transcriptase Mutations Conferring Human Immunodeficiency Virus Type 1 Resistance to Nucleoside AnaloguesJournal of Virology, 2005
- Effect of Adjunct Hydroxyurea on Helper T Cell Immunity in HIV Type 1-Infected Patients with Virological SuppressionAIDS Research and Human Retroviruses, 2004
- Mathematical Analysis of Antiretroviral Therapy Aimed at HIV-1 Eradication or Maintenance of Low Viral LoadsJournal of Theoretical Biology, 1998
- Target Cell Limited and Immune Control Models of HIV Infection: A ComparisonJournal of Theoretical Biology, 1998
- T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDSImmunology Today, 1994
- Programmed Death of T Cells in HIV-1 InfectionScience, 1992
- Cell dysfunction and depletion in AIDS: the programmed cell death hypothesisImmunology Today, 1991
- An Outbreak of Community-AcquiredPneumocystis cariniiPneumoniaNew England Journal of Medicine, 1981
- Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual MenNew England Journal of Medicine, 1981